Gaya K. Amarasinghe, PhD, Alumni Endowed Professor of Pathology and Immunology in the Department of Pathology and Immunology at Washington University School of Medicine, and a multi-institutional team of researchers were awarded a $16.8 million grant from NIH for their Ebola virus research.
The grant from NIH’s National Institute for Allergy and Infectious Disease (NIAID) will fund the team’s project, “Molecular Mechanisms of Filoviral-host Interactions,” over the next five years.
This program project grant renewal will enable us, and our network of collaborative investigators define how key host-viral interactions contribute to filovirus infections. Our studies will primarily focus on Ebola virus and Marburg virus that are known causative agents of recent outbreaks of viral hemorrhagic fever,
Gaya Amarasinghe
Dr. Amarasinghe and his team’s studies may lead to the development of drugs that treat Ebola by interfering with the viral replication process, which could help minimize outbreaks and curb epidemics in the future.